Add BrightSurf on Google Email

Beta blockers reduce death risk in patients with heart failure initiating dialysis

09.30.20 | National Kidney Foundation

Beta blockers may reduce mortality in patients with heart and kidney failure. Among 3,503 patients with heart failure initiating dialysis, 60.4% were receiving beta blockers at time of dialysis initiation; 455 died within 6 months. Compared to non-use, beta blocker use was associated with a 21% lower risk of death within 6 months of dialysis initiation after propensity score matching. These findings support use of beta blockers for patients with heart failure initiating dialysis.

###

ARTICLE TITLE: Beta Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis

AUTHORS: Hui Zhou, John J. Sim, Jiaxiao Shi, Sally F. Shaw, Ming-Sum Lee, Jonathan R. Neyer, Csaba P. Kovesdy, Kamyar Kalantar-Zadeh, and Steven J. Jacobsen

DOI: 10.1053/j.ajkd.2020.07.023

Under embargo until 3pm ET on September 30, 2020. Full text of article available by email from media contact.

American Journal of Kidney Diseases

10.1053/j.ajkd.2020.07.023

Keywords

Article Information

Contact Information

How to Cite This Article

APA:
National Kidney Foundation. (2020, September 30). Beta blockers reduce death risk in patients with heart failure initiating dialysis. Brightsurf News. https://www.brightsurf.com/news/LKNKZXWL/beta-blockers-reduce-death-risk-in-patients-with-heart-failure-initiating-dialysis.html
MLA:
"Beta blockers reduce death risk in patients with heart failure initiating dialysis." Brightsurf News, Sep. 30 2020, https://www.brightsurf.com/news/LKNKZXWL/beta-blockers-reduce-death-risk-in-patients-with-heart-failure-initiating-dialysis.html.